Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02799615 · ClinicalTrials.gov registry record
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 38
- Enrollment target
NCT02799615 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 38 participants.
The verdict
NCT02799615 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
This multicenter study is being conducted to determine whether infliximab exposure after an initial infusion is predictive of early clinical response in hospitalized pediatric patients with severe steroid-refractory UC or IBD-U. This pilot and feasibility study will establish the infrastructure, demonstrate feasibility, and collect preliminary data to support the full study.
Interventions
- DRUG Infliximab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2016-05 |
| Est. Completion | 2019-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02799615
The ClinicalTrials.gov registry entry for NCT02799615 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Infliximab is the first listed.
NCT02799615 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02799615 about?
NCT02799615 is a clinical study titled "Anti-TNF Therapy for Refractory Colitis in Hospitalized Children". This multicenter study is being conducted to determine whether infliximab exposure after an initial infusion is predictive of early clinical response in hospitalized pediatric patients with severe steroid-refractory UC or IBD-U. This pilot and feasibility study will establish the infrastructure, dem...
What is the current status of trial NCT02799615?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2016-05. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02799615?
The interventions under investigation include: Infliximab (DRUG).
Who is sponsoring clinical trial NCT02799615?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.